<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Intrapartum management and infant prophylaxis for pregnant women with HIV in resource-rich settings</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Intrapartum management and infant prophylaxis for pregnant women with HIV in resource-rich settings</h1>
<div class="graphic"><div class="figure"><div class="ttl">Intrapartum management and infant prophylaxis for pregnant women with HIV in resource-rich settings</div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="20%"></colgroup> <tbody> <tr> <td class="subtitle1_left centered align_middle" rowspan="2">Treatment and VL status of the mother</td> <td class="subtitle1_left centered align_middle" colspan="3">Received antepartum ART with no adherence concerns</td> <td class="subtitle1_left align_middle" rowspan="2"> <ul> <li>No antepartum ART*</li> <li>ART adherence concerns</li> <li>Unknown HIV RNA</li> <li>HIV diagnosis made in labor</li> <li>Acute/primary HIV during <span class="nowrap_whitespace">pregnancy<sup>¶</sup></span></li> </ul> </td> </tr> <tr> <td class="subtitle2">Undetectable VL (&lt;50 copies/mL) within 4 weeks of delivery</td> <td class="subtitle2">Detectable (≥50 copies/mL) but ≤1000 copies/mL within 4 weeks of delivery</td> <td class="subtitle2">&gt;1000 copies/mL within 4 weeks of delivery</td> </tr> <tr> <td><strong>Risk for HIV transmission</strong></td> <td>Low risk</td> <td>High risk</td> <td>High risk</td> <td>High risk</td> </tr> <tr> <td><strong>Preferred delivery mode</strong></td> <td>Determined by obstetric indications</td> <td>Determined by obstetric indications</td> <td>Scheduled cesarean delivery at 38 weeks</td> <td>Individualized based on HIV viral level (if known) and <span class="nowrap_whitespace">presentation<sup>Δ</sup></span></td> </tr> <tr> <td><strong>Intrapartum antiretrovirals</strong></td> <td>Continue baseline ART regimen</td> <td> <ul> <li>Continue baseline ART regimen</li> <li>Consider intrapartum intravenous <span class="nowrap_whitespace">zidovudine<sup>◊</sup></span></li> </ul> </td> <td> <ul> <li>Continue baseline ART regimen</li> <li>Intrapartum intravenous <span class="nowrap_whitespace">zidovudine<sup>◊</sup></span></li> </ul> </td> <td> <ul> <li>Continue baseline ART regimen if receiving ART</li> <li>Intrapartum intravenous <span class="nowrap_whitespace">zidovudine<sup>§</sup></span></li> </ul> </td> </tr> <tr> <td><strong>Other intrapartum interventions</strong></td> <td>Avoid fetal scalp electrodes</td> <td> <ul> <li>Avoid artificial rupture of membranes</li> <li>Avoid operative delivery with forceps or vacuum extractor</li> <li>Avoid fetal scalp electrodes</li> </ul> </td> <td>Avoid fetal scalp electrodes</td> <td> <ul> <li>Avoid artificial rupture of membranes (if not undergoing cesarean)</li> <li>Avoid operative delivery with forceps or vacuum extractor (if not undergoing cesarean)</li> <li>Avoid fetal scalp electrodes</li> </ul> </td> </tr> <tr> <td><strong>Infant antiretroviral prophylaxis</strong><sup>¥</sup></td> <td>2 to 4 weeks of zidovudine</td> <td>Presumptive HIV therapy</td> <td>Presumptive HIV therapy</td> <td>Presumptive HIV therapy</td> </tr> </tbody></table></div><div class="graphic_lgnd">This table reflects the general principles of intrapartum management and infant antiretroviral prophylaxis for pregnant women with HIV.</div><div class="graphic_footnotes"><p>ART: antiretroviral therapy; 
        VL: viral load.</p>
<p>* Women who present in labor with unknown HIV status (or a prior negative test with subsequent risk factors for HIV infection) should undergo rapid combination antibody/antigen HIV testing. If this test is positive, the woman and her infant should be managed as high risk for HIV transmission (having had no antepartum ART) while awaiting confirmatory testing.</p>
<p>¶ Primary HIV infection refers to the first 6 months of infection.</p>
<p>Δ In the United States, clinicians can consult with the National Perinatal HIV/AIDS Clinical Consultation Center at 1-888-448-8765 to help rapidly develop an individualized plan for individuals who present in labor or with ruptured membranes.</p>
<p>◊ Clinicians may reasonably add intrapartum zidovudine for such patients, particularly if there were concerns about adherence to ART during pregnancy. We typically use intrapartum zidovudine at this VL range.</p>
<p>§ Intrapartum zidovudine is administered intravenously with a 2 mg/kg dose followed by a continuous infusion of 1 mg/kg/hour until delivery. For women undergoing scheduled cesarean delivery, zidovudine is initiated 3 hours before the procedure. For women who present in labor and have not received antepartum ART, intravenous zidovudine should be administered immediately.</p>
    
    ¥ Refer to other UpToDate content for specifics on regimens and dosing for infant antiretroviral prophylaxis.</div><div id="graphicVersion">Graphic 110841 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
